Carlsmed's patient-specific spine implant, Aprevo, received a transitional pass-through payment from CMS.
This provides outpatient facilities with an incremental Medicare payment for procedures that use Aprevo, according to an Oct. 19 news release. The designation is part of CMS' quarterly update of the 2021 Medicare Hospital Outpatient Prospective Payment System.
The nod comes weeks after CMS granted the new technology add-on payment. Both payment reimbursement programs went into effect Oct. 1.